Managed Care


Incentive Formularies Have Minimal Effect

MANAGED CARE August 2007. © MediMedia USA
News and Commentary

Incentive Formularies Have Minimal Effect

MANAGED CARE August 2007. ©MediMedia USA

Researchers at Harvard Medical School wanted to determine the effect of changes in drug benefit design on pharmaceutical use and spending. They observed prescription drug spending by plan and member and also formulary compliance, including use of generic medications and mail-order fulfillment.

Eligible enrollees were younger than 64, had prescription drug coverage provided by the health plan, and were drawn from 11 states.

Members who switched from a two-tier to a three-tier formulary had a decrease in total drug spending of 5 percent to 15 percent. Changing to an incentive formulary with higher copayments was accompanied by a small but inconsistent decrease in the use of nonformulary selections and a concomitant rise in both generic and "formulary preferred" utilization.

"Other studies suggest that there's a tremendous behavioral response when patients switch ... to three-tier formularies," says Bruce E. Landon, MD, MBA, lead author and associate professor of medicine and health care policy at Harvard Medical School. "There is a definite measurable response, but the response isn't as big as it's been touted to be."


4th Partnering With ACOs Summit Los Angeles, CA October 27–28, 2014
PCMH & Shared Savings ACO Leadership Summit Nashville, TN November 3–4, 2014
2014 Annual HEDIS® and Star Ratings Symposium Nashville, TN November 3–4, 2014
Medicare Risk Adjustment, Revenue Management, & Star Ratings Fort Lauderdale, FL November 12–14, 2014
World Orphan Drug Congress Europe 2014 Brussels, Belgium November 12–14, 2014
Healthcare Chief Medical Officer Forum Alexandria, VA November 13–14, 2014
Home Care Leadership Summit Atlanta, GA November 17–18, 2014
HealthIMPACT Southeast Tampa, FL January 23, 2015